Macroaxis: Personalized Investing
Personalized Investing and
Digital Wealth Optimization

FNMFO FNMFO 096770 KDDIF Real Estate Large Blend Recent Drops DKK Bitcoins 
Benchmark SP 500  1,629   22.88  Index Moved Down -1.39% United States ...


Processing
Collecting data for BCR and XRAY ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 CR Bard Inc.  vs   DENTSPLY International Inc.
 Compare Fundamentals  
Daily Returns (%)
BCR   XRAY   
 
Change Benchmark  Embed  Export  Timeline
Considering 30-days investment horizon, CR Bard Inc is expected to generate 1.2 times more return on investment than DENTSPLY. However, CR Bard is 1.2 times more volatile than DENTSPLY International Inc. It trades about 0.18 of its potential returns per unit of risk. DENTSPLY International Inc is currently generating about -0.04 per unit of risk. If you would invest  10,671  in CR Bard Inc on May 20, 2013 and sell it today you would earn a total of  509  from holding CR Bard Inc or generate 4.77% return on investment over 30 days.

Diversification

Very weak diversification
Overlapping area represents amount of risk that can be diversified away by holding CR Bard Inc. and DENTSPLY International Inc. in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.44
Parameters
Time Period1 Month [change]
DirectionPositive XRAY Moved Up vs BCR
StrengthWeak
Accuracy100.0%
ValuesDaily Returns
Follow Correlation between BCR and XRAY with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between BCR and XRAY to your reader
 
Share Correlation between BCR and XRAY 
Find Opportunities
 
Predicted Return Density
 
Embed  Export  
Returns   
BCR   XRAY   

CR Bard Inc

 
    
CR Bard
Performance
9
Out Of
100
Over 30
Days
91% of all equities and portfolios perform better than CR Bard Inc. Compared with the overall equity markets, risk-adjusted returns on investments in CR Bard Inc are ranked lower than 9 (%) of all global equities and portfolios over the last 30 days.
    

Match-ups for CR Bard

Baxter International Inc vs. CR Bard Inc
Covidien plc vs. CR Bard Inc
Becton Dickinson and Company vs. CR Bard Inc
CareFusion Corporation vs. CR Bard Inc
DENTSPLY International Inc vs. CR Bard Inc
The Cooper Companies Inc vs. CR Bard Inc
Mindray Medical International Limited vs. CR Bard Inc
Teleflex Incorporated vs. CR Bard Inc
West Pharmaceutical Services Inc vs. CR Bard Inc
  

DENTSPLY International Inc

 
    
DENTSPLY
Performance
0
Out Of
100
Over 30
Days
Over the last 30 days DENTSPLY International Inc has generated negative risk-adjusted returns adding no value to investors with long positions.
    

Match-ups for DENTSPLY

Baxter International Inc vs. DENTSPLY International Inc
Covidien plc vs. DENTSPLY International Inc
Becton Dickinson and Company vs. DENTSPLY International Inc
CR Bard Inc vs. DENTSPLY International Inc
CareFusion Corporation vs. DENTSPLY International Inc
The Cooper Companies Inc vs. DENTSPLY International Inc
Mindray Medical International Limited vs. DENTSPLY International Inc
Teleflex Incorporated vs. DENTSPLY International Inc
West Pharmaceutical Services Inc vs. DENTSPLY International Inc


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium